Hinge Health (HNGE) Common Equity (2024 - 2026)

Hinge Health (HNGE) has 3 years of Common Equity data on file, last reported at $111.7 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 136.23% year-over-year to $111.7 million; the trailing twelve-month figure through Mar 2026 stood at $111.7 million (up 136.23% YoY), and the FY2025 full-year result was $178.7 million, up 141.11% from the prior year.
• Common Equity fell to $111.7 million in Q1 2026, from $178.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $208.0 million in Q3 2025 to a low of -$462.6 million in Q2 2024.
• A 3-year average of -$124.4 million and a median of -$98.3 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 145.04% in 2025 and soared 136.23% in 2026, its largest moves.
• Tracing HNGE's Common Equity over 3 years: stood at -$434.6 million in 2024, then surged by 141.11% to $178.7 million in 2025, then tumbled by 37.49% to $111.7 million in 2026.
• Business Quant data shows HNGE's Common Equity at $111.7 million in Q1 2026, $178.7 million in Q4 2025, and $208.0 million in Q3 2025.